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The immune  system of an organism  is required to be capable of responding to a 
wide spectrum of antigens. T  helper cells recognize these antigens in association with 
Ia molecules. Given that the number of different Ia molecules encoded in the genome 
is  limited,  the  possible  restriction  specificities of  the  T  cells  would  appear  to  be 
similarly limited.  However,  if T  cells could  use  more  than  one  restriction site  per 
molecule, the immune response capability of the organism would be enlarged. 
Through the use of monoclonal antibodies and monoclonal T  cell lines, it has been 
possible to establish that an individual cloned T  cell line, be it alloreactive or antigen- 
reactive, has specificity for one Ia molecule (1). Although it has not yet been possible 
to  isolate and  characterize the T  cell receptor for antigen, studies on  cloned T  cell 
lines  can  provide  indirect  information  about  the  receptor by analyzing the  nature 
and  variety of determinants with  which  the receptor interacts. These  studies might 
also reveal information about  the number of functionally important epitopes on the 
Ia molecules.  Recently,  there  have  been  reports  describing the definition of several 
serological epitopes on I-A  k molecules (2,  3).  If T  cells also can recognize more than 
one epitope on an Ia molecule, then one would expect to be able to find individual T 
cell clones specific for each epitope. 
Among the I-Ab-restricted alloreactive clones in our collection, we have identified 
one that  is capable of recognizing cells of the strain B6.C-H-2 bin12, the I-A  b mutant, 
whereas the other I-A  b restricted clones cannot. Additionally, we have found that two 
clones that  are specific for the AbA~ hybrid molecule also can  recognize bml2  cells, 
although  they do not  respond at all to the parent  strain  B6  cells. One of these two 
clones is an  alloreactive A  anti-(B6  X  A)F1 clone, whereas the other is a  L-glutamic 
acid6°-r-alanine~°-L-tyrosine  1°  (GAT)-reactive clone of (B6  x  A)F1 origin. The  iden- 
tification of these two distinct reactivity patterns suggests that  there exist both on I- 
A b molecules and on hybrid  b  k  A~A  B molecules at least two distinct epitopes recognized 
by  T  cells.  Additional  data  obtained  by  studying  monoclonal  anti-I-A  antibody 
inhibition  of stimulation  of T  cell  clones  demonstrate  a  lack  of identity  between 
serologically defined epitopes on I-A molecules and epitopes on I-A molecules recog- 
nized by cloned T  cell lines. 
Materials  and  Methods 
Mice.  C57BL/6  (B6),  A/J  (A), B6.C-H-2  hm~2 (bml2),  (B6  X  A)FI, [B6  X  B10.A(4R)]F1, 
[bml2  X  B10.A(4R)]Fi,  BALB/c,  and  (B6  X  BALB/c)FI  mice  were  purchased  from  The 
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Jackson  Laboratory,  Bar Harbor,  ME, or bred  from  the stock in our animal  facilities. Adult 
mice, aged 6-36 wk, were used in all experiments. 
Antigen  and  Culture Medium.  The  random  terpolymer  L-glutamic  acid6°-L-alanineS°-L-tyro- 
sine  1° (GAT)  (lot 9) was purchased  from Miles-Yeda Ltd.,  Rehovot, Israel. Complete culture 
medium has been previously described (1). 
T  Cell  Clones.  The procedures  and  techniques  for cloning murine  alloreactive T  cells (4) 
and antigen-reactive T  cells (5) have been previously described. 
Monoclonal Antibodies.  The  monoclonal  antibodies  used  for blocking proliferation in  these 
studies,  10-2.16  (6),  Hl16.32  (7),  and  BP107  (8)  have  been  previously  described.  Briefly, 
monoclonal antibody  10-2.16 reacts with specificity Ia.17 on the A~ chain  (1,  9).  Monoclonal 
antibody H116.32 reacts with specificity Ia.19 on the A~ chain (1). Monoclonal antibody BP107 
reacts with cells expressing I-A  b,d'p'q,ud (8). 
Proliferation  Assay.  The  techniques  used  to  assay  the  proliferative  response  have  been 
described previously (5). Briefly, 1 ×  104 alloreactive T  cells are cultured with 1 ×  10  s irradiated 
stimulator spleen cells in 0.2 ml of culture medium in flat-bottomed microtiter plates.  1 x  104 
antigen-reactive  T  cells  are  similarly  stimulated  with  200  gg/ml  GAT  (unless  otherwise 
indicated)  in the presence of  X  6 •  .  1  10  trradtated  syngenem spleen cells. Cultures were pulsed 
with  1 gCi of [aH]thymidine  at 24 h  and  harvested  16 h  later. The results of the thymidine 
incorporation  assay  are expressed  as  the  mean  counts  per  minute  of triplicate cultures.  The 
standard  deviations from replicate cultures were always within  10% of the mean value. 
Results 
Two Epitopes on LA b Molecules  Recognized by T  Cell Clones.  Among the alloreactive T 
cell  clones  that  we  have  obtained  from  long-term  A/J  anti-(B6  X  A)F1  mixed 
lymphocyte cultures, we have identified one clone specific for I-A  b, clone 11.16,  which 
is capable of recognizing stimulator cells from the I-A mutant strain B6.C-H-2  bin12 as 
well as it does stimulator cells from strain B6 (Table I). That this clone recognizes an 
H-2  b linked  determinant  is  indicated  by  its  stimulation  by A.BY  cells  and  by  its 
failure to be stimulated by strain B 10.A cells (data not shown). The observation that 
its stimulation can be blocked by monoclonal antibody  17/227, an Ia. 15 reagent  (7), 
maps the reactivity to the I-A locus  (data not shown).  Clone  11.4  and all other B6- 
reactive clones of A/J origin tested to date do not recognize bml2 stimulator cells. 
The bm 12 mutation has been mapped to I-A both genetically (10, 11) and serologically- 
TABLE  I 
Recognition of bml2 Stimulator Cells by an Alloreactive T  Cell Clone 
Stimulator cell  Haplotype 
Clone 
11.16  llA 
cprn 
K  A  E  D 
A  k  k  k  d  365  68 
B6  b  b  b  b  ~2,996  10,908 
(B6 x  A)F~  b/k  b/k  b/k  b/d  15,564  7,435 
[B6 ×  B10.A(4R)IF1  b/k  b/k  b/b  b/b  13,478  10,461 
bml2  b  b*  b  b  11,581  194 
[bml2 X BI0.A(4R)]Fa  b/k  b*/k  b/b  b/b  10,580  462 
Proliferation of 1 X 104 cells from alloreactive T cell clones measured as counts 
per minute of incorporated thymidine following a 72-h culture with a terminal 
18-h pulse with 1/tCi of tritiated thymidine. Stimulator cells are 1 x  106 spleen 
cells from the strain indicated irradiated with 3,300 rad before co-culture. The 
haplotype of the stimulator cells have been included for ease of interpretation; 
bml2 has a mutation in the I-A subregion  indicated by asterisks. 1398  DEFINITION  OF MULTIPLE  T  CELL EPITOPES  ON  I-A MOLECULES 
(12)  and has  been shown to  result in an altered A~  polypeptide (13).  We interpret 
these data to mean that clone 1 1.16 recognizes an epitope on the [-A  b molecule that 
is conserved on the I-A  brat2 molecule, whereas clone 1 1.4 recognizes an epitope which 
has been lost or altered on the I-A  brn12 molecule. 
One  Epitope  of the  I-A bm~2 Molecule  Resembles  b  k  A,AI~ ,  a  Second  Resembles  LA b.  We 
recently reported  (1)  experiments that demonstrate that among our antigen-reactive 
and alloreactive T  cell clones that are specific for hybrid I-Ab/I-A  k molecules, we can 
discriminate those recognizing the  k  b  b  k  A~A/~ molecule from  those recognizing the A~At~ 
molecule. This discrimination was based on blocking studies using monoclonal anti-I- 
A k antibodies and studies using [bml2 ×  BI0.A(4R)]F1 mice as compared with [B6 
×  B 10.A(4R)]F1 mice as sources of stimulator or antigen-presenting  cells (APC). Thus, 
we identified two alloreactive clones,  1 1.17  and  1 1.19,  which had specificity for the 
hybrid molecule AbA~.  To our surprise, one of the  clones,  11.17,  recognized bml2 
cells as well as  it did  (B6  ×  A)Ft cells, although it responded not at  all to  B6 cells 
[A bAbml2  (Table II). These data suggest that the altered I-A  b molecule ~,,~  ,, expressed by 
the bm 12 mouse now in some way resembles the AbA~ hybrid molecule. 
We have made a similar observation with Fl-restricted GAT-reactive clones of (B6 
b  k  ×  A)FI origin. Both clone 12.5.a. 1 and clone 12.5.a.31  use theA~A~ hybrid molecule 
as the restriction element for antigen recognition, based on the pattern of blocking by 
TAB  LF.  II 
Recognition of bml2 Stimulator  Cells by an Alloreactive T  Cell Clone 
Stimulator cell  Haplotype 
Clone 
11.17  11.19 
6pm 
K  A  E  D 
A  k  k  k  d  249  48 
B6  b  b  b  b  200  60 
(B6 x A)F1  b/k  b/k  b/k  b/d  10,832  4,326 
[B6 x B10.A(4R)]F1  b/k  b/k  b/b  b/b  13,071  7,914 
bml2  b  b*  b  b  10,017  69 
[bml2 × B10.A(4R)JFa  b/k  b*/k  b/b  b/b  12,079  8,357 
See legend to Table I. 
TABLE III 
Antibody Blocking of T  Cell Proliferation 
GAT-reactive clone:  12,5.a. 1  12.5.a.31  14.14 
APC:  (B6A)F1 bml2  (B6A)F~  B6 
Media control  1,164  846  138  790 
+ 200/tg GAT  22,564  7,494  5,445  20,977 
Antibody 
10-2.16 (A~)  6,793  6,646  2,056  21,396 
H116.32 (A~  23,730  7,211  5,181  18,977 
BP 107 (A~  21,513  1,482  5,410  11,764 
Inhibition ofT cell proliferation (see legend to Table I) by addition of 1  #g of 
purified antibody for the duration of the culture. The T cell clones are co- 
cultured with 1 ×  106 irradiated spleen cells as a source of APC from strains 
indicated under each T cell clone. 1399 
120 
monoclonal antibodies, as illustrated by the data in Table III.  Stimulation of both 
clones  12.5.a. 1 and  12.5.a.31  was blocked by antibody 10-2.16 (A~), but not blocked 
by antibody H116.32 (A~). In addition, neither clone was blocked by antibody BP107 
(I-A  b) when GAT was presented on (B6 ×  A)F1 APC. (We have provisionally assigned 
the reactivity of BP107 to the A~ chain based on its pattern of blocking of these and 
other T  cell clones  [data  not  shown].)  Unexpectedly, one of these clones,  12.5.a. I, 
responded to antigen when presented by bml2 spleen ceils, although neither clone 
responded to antigen presented by B6 spleen cells. We then tested whether recognition 
of GAT as presented by bm 12 APC to clone 12.5.a. 1 could be blocked by antibodies 
in the same way as could presentation by (B6 ×  A)Fx APC. As is illustrated in Table 
III, antibody 10-2.16 was unable to block stimulation of clone 12.5.a. 1 in the presence 
of GAT  and  bml2  APC,  but  antibody  BP107  was  quite  effective  under  these 
conditions. These blocking reactions are exactly the converse of the pattern obtained 
with (B6 ×  A)F1 APC. These results suggest that the epitope recognized by this T  cell 
clone  and  the  epitopes  recognized  by  these  antibodies  are  not  concordant.  Our 
previous results have indicated that monoclonal antibody blocking studies can identify 
the  particular  Ia  molecule that  a  T  cell  clone is  recognizing.  The current  results 
suggest, however, that blocking with monoclonal antibodies cannot be used to identify 
specific epitopes on a given Ia molecule. 
Different Antigen Presenting Capabihties of (B6 × A)F1 and bm 12 APC.  While analyz- 
ing the unexpected response of GAT-reactive clone 12.5.a. 1 to GAT when presented 
by bm 12 spleen cells, we noticed that the level of response to the usual concentration 
of GAT when presented by bm 12 APC was less than optimal. Thus, we examined the 
proliferative response of this clone to varying antigen concentration in the presence of 
several different sources of APC. As shown by the data presented in Fig.  1 A, clone 
12.5.a. 1 responded optimally to GAT at concentrations of 100 #g/ml and above when 
presented by  (B6  X  A)F1 or by [bml2  X  B10.A(4R)]F1  cells, whereas  the optimal 
response  to  GAT  presented  by  bml2  cells  was  not  achieved  until  the  antigen 
concentration was increased to  1 mg/ml.  The data presented in Fig.  1 B show that 
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FIG.  1.  Strain of antigen presenting cells versus antigen concentration. Proliferation of 104 cloned 
T  cell  (as described  in  Legend to Table I)  was measured with  increasing concentration of GAT 
and  106 irradiated  spleen cells from  (136 X  A)F1  ([~);  [bml2  X  B10.A(4R)]F1  (~);  bml2  (...); 
(BALB/c X B6)F1  (~);  BALB/c (0); or B6 (O). Panel A: clone 12.5.a. 1; panel B: clone 12.5.a.31. 1400  DEFINITION OF  MULTIPLE T  CELL EPITOPES ON  I-A MOLECULES 
clone  12.5.a.31  achieved the optimal response to GAT again at  100-200/*g/ml when 
presented by (B6 ×  A)F1  or by (bml2 ×  B10.A(4R))F1  cells, but did not respond to 
GAT presented by bml2 cells at any concentration.  This observed difference in the 
ability of bm 12 spleen cells to present GAT as compared with (B6 ×  A)F1 spleen cells 
may be a function of the lower cell surface density of I-A molecules on bm 12 cells (see 
Discussion).  We  also  tested  the  ability  of spleen  cells  from  BALB/c  and  (B6  × 
BALB/c)FI animals to present antigen to GAT-reactive clones 12.5.a.1  and 12.5.a.31. 
This  was  done  because of the  remote possibility that  the  bml2  mutation  resulted 
from gene conversion in the original  (B6  ×  BALB/c)F1  mutant animal  (see  Discus- 
sion). According to this hypothesis, the apparent "k-ness" of rheA}  rolz chain might be 
the result of the exchange of a segment of A~  for A~, and the hybrid molecule, A~At~,b  d 
expressed on  (B6  ×  BALB/c)F1 cells, might also appear "k-like". However, neither 
clone 12.5.a.1  nor clone 12.5.a.31  responded to antigen in the presence of BALB/c or 
(B6 ×  BALB/c)F1 APC (Fig.  1A and B). 
Discussion 
The  Origin of the  bml2  Mutation.  The  experiments we  have described  in  this  re- 
port  have  used  the  B6.C-H-2  bin12 mouse,  and  therefore  the  interpretation  of these 
experiments depends upon what  is known about the bml2 mutation.  Both serologi- 
cally and genetically, the mutation has been mapped to the I-A region of the b haplo- 
type  (10-12)  and  the biochemical data suggest that  the locus of the mutation  is  in 
fact  the A~  gene  (13,  14). There  are  no  data  conflicting with  this  conclusion.  The 
mutation  arose  spontaneously  and  was  initially  detected  by  skin  grafting  in  a 
(C57BL/6  X  BALB/c)F1 mouse in a screening program for measuring the mutation 
rates of histocompatibility loci (15).  The original mutant mouse rejected B6 skin, but 
accepted both BALB/c and B6.C-H-2  d grafts and transmitted this mutant phenotype 
to half its progeny. The mouse itself had parents that were phenotypically normal by 
skin grafting. The most probable interpretation  is that this mouse resulted from the 
union  of a  normal gamete from the  BALB/c parent with  a  gamete carrying a  new 
mutation  from the  B6  parent.  The  mutant  mouse was then  backcrossed to  the  B6 
strain to initiate the formation of the congenic line B6.C-H-2  b'nlz, which should differ 
from the parent B6 strain only at the mutant site in LA  b. 
Our observation that two clones whose restriction specificity was known to be the 
AbA~ hybrid molecule were also able to recognize A bin12 (AbA~  m12)  molecules might 
lead one to suggest that the a~  n~12 chain had acquired k-ness. One could imagine that 
this could have resulted from a gene conversion event, during which a small segment 
of the  A}  gene  was  replaced  with A~  information.  However, the  expression  of the 
mutant phenotype in the original Fa animal and its subsequent  transmission of this 
phenotype argues strongly against  this  hypothesis.  Nonetheless,  because the experi- 
ment could be easily done, we did test whether  either of the Fl-specific clones that 
could  recognize  bml2  cells would  recognize  (B6  X  BALB/c)F1  spleen  cells,  asking 
whether Ab/A  d hybrid molecules might  resemble AbA}  molecules in  the way A bma2 
molecules apparently do  for these clones.  The data  in  Fig.  1 show that  neither  Fa- 
restricted  GAT clone responded  to antigen  presented  by  (B6  X  BALB/c)F1  spleen 
cells to any greater extent  than they did to either B6 or BALB/c APC, nor did the 
alloreactive clone 11.17 respond to stimulation by (B6 ×  BALB/c)F1 spleen cells (data 
not shown). BECK, NELSON,  AND  FATHMAN  1401 
There Must Exist at Least  Two T  Cell Epitopes on I-A Molecules.  The observation that 
two cloned T  cell lines with specificity for the I-A  b molecule show differential reactivity 
to the I-A  bma2 molecule suggests that these two cell lines possess different receptors for 
the I-A  b alloantigen.  The data indicate that the determinant  on LA  b with which the 
clone  11.4  receptor  interacts  is  not  expressed  on the  I-A  bin12 molecule,  whereas  the 
determinant  recognized by clone  11.16 has been retained.  In parallel,  the serological 
data indicate that some determinants  are retained  and others missing on the I-A  bm~2 
molecule  (16,  17).  It  seems  reasonable  to conclude that  these  two T  cell  clones are 
recognizing distinct  epitopes on the LA  b molecule. An alternative  hypothesis is that 
there are two distinct  I-A  b molecules, one of which is altered in the bm 12 mutant.  In 
this case, each of these two clones would be specific for one of the two molecules. To 
date  there  are  no  data  that  specifically  indicate  the  existence  of  multiple  I-A  b 
molecules. And, in fact, the peptide mapping experiments demonstrating that the A B 
polypeptide is altered in the bm 12 mouse suggest that there is only one species of A~ 
polypeptide expressed  (13,  14). Furthermore,  recent experiments analyzing the struc- 
ture and organization of the A~ gene(s)  at  the DNA level suggest very strongly that 
there is only one Aa gene per haploid genome. 1 
We interpret  the experiments on the I-Ab/I-Ak-reactive clones in a similar manner. 
We had assigned the specificity of clones 11.17 and  11.19 to the A~A~ molecule based 
on  the  pattern  of inhibition  of stimulation  with  monoclonal  antibodies  and  on 
recognition  of [bml2  ×  B10.A(4R)]F1  spleen  cells  (1).  The  observation  that  clone 
11.17  recognizes bml2,  whereas  11.19 does not, again suggests that  two clones with 
apparent specificity for the same molecule, "  "  b  k  m this caseA,A~, possess different receptors 
for  this  molecule,  implying  that  they  recognize  distinct  epitopes  on  this  molecule. 
Exactly the same argument applies to the GAT-reactive clones 12.5.a. 1 and  12.5.a.31. 
The Effect of Antigen Dose on the Presentation  of GA T by bm 12 Spleen Cells.  In serological 
and biochemical studies of the expression of Ia molecules by bm 12 spleen cells, it has 
been observed that these cells express fewer Ia molecules per cell than do the parent 
B6 cells  (16). We routinely observed that GAT-reactive clone  12.5.a.1  responded less 
well to presentation of antigen by bm 12 cells than it did to presentation of antigen by 
(B6 X  A)F1 or [bml2  ×  B10.A(4R)]F1 cells. This may be due to a  less than optimal 
density of Ia molecules on the bm 12 spleen cells. If, as Cohen and Eisen have suggested 
(18),  the  complex  of antigen  and  restricting  element,  be  it  Ia or H-2K or  D,  is  a 
strictly  concentration-dependent  phenomenon  and  not  a  stereo-specific  interaction, 
then one might expect to override a deficiency in the concentration of one component 
by  increasing  the  concentration  of the  other  component.  In  fact,  we  found  that 
increasing the concentration of GAT to  1 mg/ml from the standard assay concentra- 
tion of 200/~g/ml did boost the response of clone  12.5.a. 1 cells to GAT presented  by 
bml2 cells to the level of response achieved in the presence of (B6 ×  A)F1 cells. This 
result  is  consistent  with  the  concentration  dependence  hypothesis,  but  in  no  way 
proves it. Similarly, other investigators have reported (19-21) that T  cell proliferation 
to antigen  is  dependent  on the  quantity  of Ia on the surface of antigen  presenting 
cells. The observation that the alloreactive clones that recognize bm 12 are stimulated 
to  the  same  extent  by  bml2  as  by  the  nonmutant  spleen  cells  suggests  that  for 
alloreactivity,  the  surface  density  of I-A on  bmt2  cells  must  be  sufficient.  In  the 
1 Robinson,  R.  R.,  R.  N.  Germain,  D. J.  McKean,  M.  Mescher, and J.  G.  Seidman. Extensive 
polymorphism surrounding the single murine Ia Ap chain gene. Manuscript submitted for publication. 1402  DEFINITION OF  MULTIPLE T  CELL EPITOPES ON  I-A MOLECULES 
alloreactive  response  there  is  no  requirement  for  complex  formation  between  Ia 
molecules and any other antigen.  There are also other possible explanations  for the 
decreased efficiency of antigen presentation by bm 12 spleen cells. The T  cell receptor 
of clone 12.5.a. 1 may have a lower affinity for the AbA~mlZ-GAT complex as compared 
with the A~-GAT  complex. Alternatively, the bm 12 spleen cells may not "process" 
GAT as efficiently as the nonmutant spleen cells. Given the origin of the bm 12 strain, 
however,  it  seems  unlikely  that  there  would  be  a  difference  in  antigen-presenting 
ability  between  the  bml2  and  parent  cells,  unless  I-A  molecules  themselves  are 
directly involved in the processing steps.  Finally, one could propose that GAT does 
not complex as efficiently with AbA~  m12 molecules as it does with AbA~  molecules on 
the  surface  of the  APC.  Such  hypothetical  complexes have not  been  amenable  to 
isolation, so this hypothesis is not currently testable. 
The Inhibition by Certain anti I-A  Antibodies of T  Cell Recognition of Antigen Is a Steric 
Effect  and  Is  Not  Mediated  through Direct Competition for  the  Same Epitope.  The  data 
presented in Table III clearly show that the epitopes recognized by certain monoclonal 
antibodies on Ia molecules are not the same epitopes or restriction sites used by these 
antigen-reactive T  cell  clones.  The ability of monoclonal  antibodies  to  inhibit  the 
recognition of GAT by clone  12.5.a.1, when presented by APC of (B6 ×  A)F1 mice, 
is clearly different from the inhibition seen when clone 12.5.a. 1 is presented GAT by 
APC  of strain bml2. Thus,  the antibody BP107,  which  has no inhibitory effect on 
GAT  presentation  to  clone  12.5.a. 1 by  (B6  ×  A)F1  APC,  totally  inhibits  antigen 
presentation  to clone  12.5.a. 1 by bm 12 APC.  Conversely, whereas antibody  10-2.16 
inhibits the presentation of GAT by (B6 ×  A)F1 APC to clone 12.5.a. 1, this antibody 
has no inhibitory effects on antigen presentation by bm 12 cells. These results indicate 
two important  findings.  The first is that the antibody BPI07, which  may recognize 
an  epitope  on  the  beta  chain  of I-A  b  molecules,  retains  its  reactivity  for  bml2, 
suggesting that this epitope has not been changed by the mutational event. Hov,  ever, 
the mutational event has changed the ability of bm 12 cells to present antigen to clone 
12.5.a.1.  Thus,  it  is  quite  clear  that  the  mutation  that  has  altered  the  antigen 
presentation/restriction  site has not altered the epitope recognized by this antibody; 
yet this antibody is capable of inhibiting the presentation of GAT to clone 12.5.a. 1 by 
hml2  cells.  Second,  that  antibody  10-2.16  blocks the ability of (B6  ×  A)F~  APC to 
present GAT to clone 12.5.a. i, while not affecting the antigen presentation capabilities 
of bm 12 cells, suggests that the antigen-presenting site on bm 12 cannot be identical 
to this serologically defined epitope. However, this antibody blocks GAT presentation 
by (B6 ×  A)I cells, suggesting again that the restriction site for antigen presentation 
is  not  identical  to  the  site  recognized  as  an  epitope  by  the  monoclonal  anti  I-A 
antibody. 
These data provide strong evidence for the existence of multiple functional restric- 
tion sites on a  given molecular Ia complex. Although  this functional study does not 
reveal the physical nature of a restriction site, it suggests that the number of potential 
functional Ia restriction sites is much greater than the number of Ia molecules encoded 
in  the genome. Thus,  the immune response of an animal to any particular antigen 
can potentially be enhanced through the use of multiple restriction sites on a given Ia 
molecule, as well as through the use of novel Ia molecules generated by combinatorial 
association of a  and/3 chains in heterozygous individuals. BECK, NELSON,  AND  FATHMAN  1403 
Summary 
The experiments  presented  in this study demonstrate  that there exist at  least  two 
functional epitopes on an I-A molecule that  can be recognized by T  cell clones.  By 
comparing  the  abilities  of spleen  cells  from  C57BL/6  mice  and  the  congenic  I-A 
mutant  line B6.C-H-2  bin12 to stimulate  alloreactive T  cell clones specific for the I-A  b 
molecule, we have discriminated  two sets of clones, those recognizing the LA  b and I- 
A bm12 molecule equally well and those able to recognize only the LA  b molecule. These 
results imply that the two sets of clones have different receptors for I-A and that they 
therefore  recognize separate  epitopes  on  the  I-A molecule.  We have similarly  been 
able to separate  T  cell  clones, both  alloreactive  and  L-glutamic acid6°-i:alaninea°-L  - 
b  k  tyrosinei°-reactive,  specific  for the A,Aa  hybrid  molecule  into two groups based  on 
their ability to recognize bml2 spleen cells. Although the recognition of bm 12 spleen 
cells by these clones was unexpected since none of them responds to B6 spleen  cells, 
these  data  again  allow  us  to  conclude  that  these  groups  of clones  have  different 
receptors for the same I-A molecule and therefore that they recognize distinct epitopes 
on the  molecule.  Additional  studies,  in which  monoclonal anti-I-A antibodies  were 
used to block the stimulation ofT cells by stimulator or antigen-presenting cells, have 
demonstrated that this blockade can be a steric effect and therefore is not necessarily 
indicative of direct competition between the antibody and the T  cell for the same site 
on an I-A molecule. 
Although this study does not  reveal  the physical nature  of an I  region-controlled 
"antigen-restriction  site,"  we  can  suggest  that  increasing  the  number  of possible 
functional  Ia restriction  sites  either  through combinatorial  association of alpha  and 
beta chains or by using more than one site per molecule will increase the number of 
configurations the ternary complex of Ia, antigen and T  cell receptor(s)  can form. 
The authors wish to thank Dr. David McKean for thoughtful review of the manuscript, Theresa 
Lee for secretarial assistance,  and Theresa Kimlinger and Diane Infante for excellent technical 
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